215 related articles for article (PubMed ID: 19764436)
21. Genetic evaluation of the serotonergic system in chronic fatigue syndrome.
Smith AK; Dimulescu I; Falkenberg VR; Narasimhan S; Heim C; Vernon SD; Rajeevan MS
Psychoneuroendocrinology; 2008 Feb; 33(2):188-97. PubMed ID: 18079067
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomics of antidepressant drugs.
Horstmann S; Binder EB
Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
[TBL] [Abstract][Full Text] [Related]
23. Relationship between three serotonin receptor subtypes (HTR3A, HTR2A and HTR4) and treatment-resistant schizophrenia in the Japanese population.
Ji X; Takahashi N; Saito S; Ishihara R; Maeno N; Inada T; Ozaki N
Neurosci Lett; 2008 Apr; 435(2):95-8. PubMed ID: 18359159
[TBL] [Abstract][Full Text] [Related]
24. Functional variation in the 3' untranslated region of the serotonin transporter in human and rhesus macaque.
Vallender EJ; Priddy CM; Hakim S; Yang H; Chen GL; Miller GM
Genes Brain Behav; 2008 Aug; 7(6):690-7. PubMed ID: 18445138
[TBL] [Abstract][Full Text] [Related]
25. [Postoperative pain management following orthognathic surgery in consideration of individual differences--is the antinociceptive effect of fentanyl related to the genotype involving nucleotide at OPRM1?].
Fukuda K; Hayashida M; Ikeda K
Masui; 2009 Sep; 58(9):1102-8. PubMed ID: 19764432
[TBL] [Abstract][Full Text] [Related]
26. [Study of 5-HT related genes as possible etiological agents in schizophrenia].
Ozaki N
Seishin Shinkeigaku Zasshi; 2002; 104(6):501-8. PubMed ID: 12373805
[No Abstract] [Full Text] [Related]
27. Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications.
Camilleri M
Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():40-5. PubMed ID: 17620087
[TBL] [Abstract][Full Text] [Related]
28. [Genetic polymorphisms and human sensitivity to pain and opioids].
Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
[TBL] [Abstract][Full Text] [Related]
29. [Genetic background of chronic fatigue syndrome].
Narita M; Narita N
Nihon Rinsho; 2007 Jun; 65(6):997-1002. PubMed ID: 17561688
[TBL] [Abstract][Full Text] [Related]
30. Association of morphine-induced antinociception with variations in the 5' flanking and 3' untranslated regions of the mu opioid receptor gene in 10 inbred mouse strains.
Shigeta Y; Kasai S; Han W; Hata H; Nishi A; Takamatsu Y; Hagino Y; Yamamoto H; Koide T; Shiroishi T; Kasai K; Tsunashima K; Kato N; Ikeda K
Pharmacogenet Genomics; 2008 Nov; 18(11):927-36. PubMed ID: 18854775
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetics in pain management: the clinical need.
Webster LR
Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063
[TBL] [Abstract][Full Text] [Related]
32. Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.
Al Hadithy AF; Ivanova SA; Pechlivanoglou P; Semke A; Fedorenko O; Kornetova E; Ryadovaya L; Brouwers JR; Wilffert B; Bruggeman R; Loonen AJ
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):475-81. PubMed ID: 19439249
[TBL] [Abstract][Full Text] [Related]
33. Serotonin 5-HT2A receptor gene variants influence antidepressant response to repeated total sleep deprivation in bipolar depression.
Benedetti F; Barbini B; Bernasconi A; Fulgosi MC; Colombo C; Dallaspezia S; Gavinelli C; Marino E; Pirovano A; Radaelli D; Smeraldi E
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1863-6. PubMed ID: 18801406
[TBL] [Abstract][Full Text] [Related]
34. [Individual differences in analgesic effects of narcotics].
Ide S; Kasai S; Ikeda K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):43-8. PubMed ID: 18411709
[TBL] [Abstract][Full Text] [Related]
35. [Genetic background of irritable bowel syndrome].
Hagymási K; Tulassay Z
Orv Hetil; 2006 Jun; 147(25):1167-70. PubMed ID: 16893132
[TBL] [Abstract][Full Text] [Related]
36. [Influence of serotonin (5-HT) 2A-receptor and transporter (5HTT) gene polymorphism upon the effect of olanzapine].
Iwahashi K; Murayama O; Aoki J; Watanabe M; Ishigouoka J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Aug; 29(4):141-4. PubMed ID: 19764480
[TBL] [Abstract][Full Text] [Related]
37. Serotonin-2A receptor gene polymorphisms are associated with serotonin-induced platelet aggregation.
Shimizu M; Kanazawa K; Matsuda Y; Takai E; Iwai C; Miyamoto Y; Hashimoto M; Akita H; Yokoyama M
Thromb Res; 2003; 112(3):137-42. PubMed ID: 14967409
[No Abstract] [Full Text] [Related]
38. Serotonin-2A receptor gene T102C polymorphism in patients with dyspeptic symptoms.
Tahara T; Arisawa T; Shibata T; Nakamura M; Wang F; Hirata I; Nakano H
Hepatogastroenterology; 2008; 55(86-87):1921-4. PubMed ID: 19102423
[TBL] [Abstract][Full Text] [Related]
39. Genetic factors in pain and its treatment.
Stamer UM; Stüber F
Curr Opin Anaesthesiol; 2007 Oct; 20(5):478-84. PubMed ID: 17873601
[TBL] [Abstract][Full Text] [Related]
40. No causal role for the G482T and G689T polymorphisms in translation regulation of serotonin transporter (SLC6A4) or association with attention-deficit-hyperactivity disorder (ADHD).
Banerjee E; Sinha S; Chatterjee A; Nandagopal K
Neurosci Lett; 2009 May; 454(3):244-8. PubMed ID: 19429092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
